Cargando…
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2.2 and PRIME2.0 reveal potent SARS-CoV-2 CD8(+) T-cell epitopes
The recognition of pathogen or cancer-specific epitopes by CD8(+) T cells is crucial for the clearance of infections and the response to cancer immunotherapy. This process requires epitopes to be presented on class I human leukocyte antigen (HLA-I) molecules and recognized by the T-cell receptor (TC...
Autores principales: | Gfeller, David, Schmidt, Julien, Croce, Giancarlo, Guillaume, Philippe, Bobisse, Sara, Genolet, Raphael, Queiroz, Lise, Cesbron, Julien, Racle, Julien, Harari, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811684/ https://www.ncbi.nlm.nih.gov/pubmed/36603583 http://dx.doi.org/10.1016/j.cels.2022.12.002 |
Ejemplares similares
-
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting
por: Schmidt, Julien, et al.
Publicado: (2021) -
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
por: Genolet, Raphael, et al.
Publicado: (2023) -
Sensitive and frequent identification of high avidity neo-epitope specific CD8(+) T cells in immunotherapy-naive ovarian cancer
por: Bobisse, Sara, et al.
Publicado: (2018) -
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
por: Arnaud, Marion, et al.
Publicado: (2021) -
The MHC Motif Atlas: a database of MHC binding specificities and ligands
por: Tadros, Daniel M, et al.
Publicado: (2022)